PHARMA LITERATI

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed. We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at  pharmaliterati@gmail.com Invention Application number Inventors Institute A novel synergistic medicinal composition for the treatment of gout and process for preparation of the same 201611021396A 1) Laxmi Kant Sharma Not known Composition for the treatment of urolithiasis 292/DEL/2014A 1) Shivkanya Fuloria   2) Neeraj Kumar Fuloria 3) S. A. Dhanaraj 4) Arati Ashok Patil Not known An improved method for qu...

Colorcon Inc . and The Dow Chemical Company announced an agreement to broaden the existing Controlled Release Alliance between the two companies. While the Alliance currently provide controlled release technologies from Dow Pharma & Food Solutions, a business unit of Dow, to customers, effective January 1, 2017, it will be extended to include Dow’s advanced technology based pharmaceutical excipients. The Alliance has served the needs of the pharmaceutical industry, since announced in July 2007, providing customized solutions, products and support services for pharmaceutical product development. The addition of new technologies into the Alliance product portfolio expands the existing relationship between Colorcon and Dow and further enables formulation and development of fast-growing pharmaceutical applications, beyond the existing controlled release scope. “ This new phase reaffirms the long-standing commitment between the two companies to grow together and leverage the...

It is not only tumours and metastases that differ in each type of cancer and each individual sufferer but also receptors in cells. It is therefore important to stop thinking of diagnostic methods such as molecular imaging and pathology, data analysis and ultimately clinical pharmacology for the development of new drugs as being separate from each other but instead to combine the individual specialisms and their methods – with the aim of increasing response rates to effective, personalised cancer treatments. This was emphasised by experts from MedUni Vienna on the occasion of the first " Donau Symposium ", a forum for the interdisciplinary development of cancer treatments that will take place in the Van Swieten Hall of the Medical University of Vienna from Wednesday to Friday. This interdisciplinary approach is already being practised at MedUni Vienna to find targets for cancer diagnosis and treatment. Molecular imaging at the Division of Nuclear Medicine, in which dru...

Take a moment to think about your health over the last year. How often have you taken a painkiller to manage that headache or fever? These powerful tools have the ability to save you from a day of pain, allowing the survival of that long shift at work or half-marathon which has slowly crept up on you. How many relatives or friends have had their health improved through life saving medications such as chemotherapy or anti-depressants. There are a large variety of medications widely used today that have transformed our lives and we would struggle in a world without them. Many are aware that it is advances in medical research which have enabled the development and availability of these. However, it is often forgotten that when developing such drugs scientists will usually take their inspiration from similar compounds found in nature. But where? This article gives much deserved recognition to nature’s own pharmacologists . After all, these magicians are our true heroes. So, what nat...

“ I was facing a life-and-death situation two weeks ago. I nearly ran out of a life-saving medicine and I was wondering what to do .” Thus began a desperate online petition by a thalassaemia patient, Namitha Kumar, research director of the Centre for Health Ecologies and Technology (CHET) at the Indian Institute of Science, Bengaluru . The petition was tagged to draw the attention of health minister J.P. Nadda to the shortage of the injectable drug Desferal in early September. The supply has since been restored. But, says Kumar, her fresh stock will last her for just another month, and it is unclear whether there will be an assured supply of the drug after. “ The drug supply has been irregular for the past one year ,” she told The Wire. “This August, we did not get the drug in Bengaluru. It has also run dry in Delhi, Mumbai, parts of Assam, Gujarat and Maharashtra. And on September 5 and 6, Vishwanath Muralidharan, secretary of the National Platform for the Rights of the Dis...

Docplexus was founded in January, 2014 when Phanish Chandra lost his brother to an illness that took too long to diagnose. With this initiative, Phanish hopes to create a network of medical professionals who can quickly connect with each other to collaborate on patient treatment or identify the appropriate expert for patient referrals so that other lives won’t be lost due to delay in treatment. Here’s more from Phanish Chandra, CEO and founder of Docplexus. There is a profound story behind why you started Docplexus ; tell us about it. I am from a family of doctors and many of my family members are doctors. But younger brother Manish and I chose engineering over medicine and graduated from IIT. A few years into his job Manish fell ill and we desperately tried to diagnose his illness. It took almost 8 months to find out that he was suffering from Neurocysticercosis. However, by the time he was diagnosed, it was too late. We lost him in an unfortunate way. It was a big shock f...

With the mandatory Uniform Code for Pharmaceutical Marketing Practice (UCPMP) expected to be released soon by the Department of Pharmaceuticals (DoP), experts in the industry maintain that companies should turn to technologies like digital marketing platforms. Companies can take advantage of the competitive tariffs offered by telecom service providers, concurred experts at the recently concluded KDPMA –DOP workshop as they see the new rules to reshape the sales and marketing operations. According to Ganesh Nayak, chief operating officer and executive director, Zydus Cadila Healthcare , UCPMP is a positive move and provides a level playing field. As the country is evolving and working to reinstate its supremacy on global arena, pharma industry needs to build a future with ethical practices. “ UCPMP is a new era in pharma marketing. It will add the much needed value to product branding. The quality perception is as strong as the brand which enhances the company’s image to...